BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28934861)

  • 1. Long Noncoding RNAs in Diabetes and Diabetic Complications.
    Leung A; Natarajan R
    Antioxid Redox Signal; 2018 Oct; 29(11):1064-1073. PubMed ID: 28934861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of long non-coding RNA in diabetes mellitus and its complications].
    Li A; Zhang Z
    Sheng Wu Gong Cheng Xue Bao; 2016 Mar; 32(3):284-91. PubMed ID: 27349111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications.
    Zhu L; Li Y; Xia F; Xue M; Wang Y; Jia D; Gao Y; Li L; Shi Y; Chen S; Xu G; Yuan C
    Curr Pharm Des; 2022; 28(12):1011-1018. PubMed ID: 34895118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs: The hidden players in diabetes mellitus-related complications.
    Hussein RM
    Diabetes Metab Syndr; 2023 Oct; 17(10):102872. PubMed ID: 37797393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA as a regulator in the development of diabetic complications.
    Geng M; Liu W; Li J; Yang G; Tian Y; Jiang X; Xin Y
    Front Endocrinol (Lausanne); 2024; 15():1324393. PubMed ID: 38390204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking diabetic vascular complications with LncRNAs.
    Leung A; Amaram V; Natarajan R
    Vascul Pharmacol; 2019 Mar; 114():139-144. PubMed ID: 29398367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
    Yao K; Wang Q; Jia J; Zhao H
    Tumour Biol; 2017 Jun; 39(6):1010428317707882. PubMed ID: 28639886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease.
    Srivastava SP; Goodwin JE; Tripathi P; Kanasaki K; Koya D
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential regulatory mechanisms of lncRNA in diabetes and its complications.
    Feng SD; Yang JH; Yao CH; Yang SS; Zhu ZM; Wu D; Ling HY; Zhang L
    Biochem Cell Biol; 2017 Jun; 95(3):361-367. PubMed ID: 28177764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNAs and Cardiac Disease.
    Greco S; Salgado Somoza A; Devaux Y; Martelli F
    Antioxid Redox Signal; 2018 Sep; 29(9):880-901. PubMed ID: 28699361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Role of Long Non-Coding RNAs in Diabetic Vascular Complications.
    Tanwar VS; Reddy MA; Natarajan R
    Front Endocrinol (Lausanne); 2021; 12():665811. PubMed ID: 34234740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNAs and circular RNAs as endothelial cell messengers in hypertension: mechanism insights and therapeutic potential.
    Zhang JR; Sun HJ
    Mol Biol Rep; 2020 Jul; 47(7):5535-5547. PubMed ID: 32567025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
    Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus.
    Zhang W; Zheng J; Hu X; Chen L
    Endocrine; 2019 Sep; 65(3):494-503. PubMed ID: 31346922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.
    Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD
    BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
    Guo J; Liu Z; Gong R
    Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 as a Diagnostic and Therapeutic Target in Diabetes-Related Complications: A Promising Long-Noncoding RNA.
    Abdulle LE; Hao JL; Pant OP; Liu XF; Zhou DD; Gao Y; Suwal A; Lu CW
    Int J Med Sci; 2019; 16(4):548-555. PubMed ID: 31171906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of long noncoding RNAs and small extracellular vesicle-long noncoding RNAs in type 2 diabetes.
    Chang W; Wang M; Zhang Y; Yu F; Hu B; Goljanek-Whysall K; Li P
    Traffic; 2022 Nov; 23(11):526-537. PubMed ID: 36109347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal long noncoding RNAs are associated with glycemic control after bariatric surgery in high-fat diet-induced diabetic mice.
    Liang Y; Yu B; Wang Y; Qiao Z; Cao T; Zhang P
    Surg Obes Relat Dis; 2017 Jul; 13(7):1212-1226. PubMed ID: 28366671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.